Results 231 to 240 of about 26,042 (243)

Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria

Journal of Clinical Oncology, 2007
Shreyaskumar R Patel
exaly  

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

Lancet, The, 2009
Ronald P Dematteo, Karla V Ballman, Robert G Maki   +2 more
exaly  

Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

Lancet Oncology, The, 2010
François Guilhot, Laurence Legros, Gabriel Etienne   +2 more
exaly  

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

Lancet, The, 2004
Jaap Verweij, Paolo Giovanni Casali, John Zalcberg   +2 more
exaly  

Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

Journal of Clinical Oncology, 2008
Charles D Blanke, Margaret von Mehren, Robert G Maki   +2 more
exaly  

Hypopigmentation from Imatinib Mesylate (Gleevec)

Journal of Pediatric Hematology/Oncology, 2004
William J, Grossman, David B, Wilson
openaire   +2 more sources

Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial

Leukemia, 2016
Andreas Hochhaus, Giuseppe Saglio
exaly  

Discontinuation of imatinib may be possible in chronic myelogenous leukemia

Ca-A Cancer Journal for Clinicians, 2011
exaly  

Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate

Cancer Cell, 2010
Leonard D Shultz, Tessa L Holyoake, Ravi Bhatia   +2 more
exaly  

Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

Journal of Clinical Oncology, 2008
Robert G Maki, Cristina R Antonescu, Wen-Bin Ou   +2 more
exaly